Trust Co. of Toledo NA OH Sells 423 Shares of CVS Health Co. (NYSE:CVS)

Trust Co. of Toledo NA OH cut its stake in CVS Health Co. (NYSE:CVS) by 1.2% during the 1st quarter, HoldingsChannel.com reports. The fund owned 35,491 shares of the pharmacy operator’s stock after selling 423 shares during the period. Trust Co. of Toledo NA OH’s holdings in CVS Health were worth $2,405,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. Stonebridge Financial Group LLC bought a new stake in CVS Health in the fourth quarter valued at approximately $28,000. Hopwood Financial Services Inc. bought a new position in shares of CVS Health during the 4th quarter worth approximately $29,000. McIlrath & Eck LLC boosted its holdings in shares of CVS Health by 32.6% during the 4th quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator’s stock worth $32,000 after buying an additional 174 shares in the last quarter. MV Capital Management Inc. boosted its holdings in shares of CVS Health by 63.9% during the 1st quarter. MV Capital Management Inc. now owns 741 shares of the pharmacy operator’s stock worth $50,000 after buying an additional 289 shares in the last quarter. Finally, Financial Perspectives Inc boosted its holdings in shares of CVS Health by 137.5% during the 4th quarter. Financial Perspectives Inc now owns 805 shares of the pharmacy operator’s stock worth $36,000 after buying an additional 466 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors.

Insider Activity at CVS Health

In other news, Director Guy P. Sansone bought 1,570 shares of the stock in a transaction on Thursday, June 5th. The stock was acquired at an average cost of $63.70 per share, for a total transaction of $100,009.00. Following the acquisition, the director now owns 12,007 shares of the company’s stock, valued at $764,845.90. This represents a 15.04% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 1.22% of the stock is owned by company insiders.

Analyst Ratings Changes

CVS has been the topic of a number of research analyst reports. Wall Street Zen upgraded CVS Health from a “hold” rating to a “buy” rating in a report on Friday, May 9th. UBS Group increased their price target on CVS Health from $67.00 to $71.00 and gave the stock a “neutral” rating in a report on Friday, May 2nd. Cowen restated a “buy” rating on shares of CVS Health in a report on Monday, May 5th. Morgan Stanley reiterated an “overweight” rating on shares of CVS Health in a report on Tuesday, April 15th. Finally, JPMorgan Chase & Co. increased their target price on CVS Health from $80.00 to $81.00 and gave the stock an “overweight” rating in a report on Tuesday, February 18th. Two analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, CVS Health has an average rating of “Moderate Buy” and a consensus target price of $74.75.

CVS Health Price Performance

Shares of CVS Health stock opened at $67.42 on Friday. The stock has a market cap of $85.29 billion, a price-to-earnings ratio of 18.42, a price-to-earnings-growth ratio of 0.98 and a beta of 0.56. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.60 and a current ratio of 0.81. The stock has a 50 day moving average price of $65.15 and a 200-day moving average price of $60.15. CVS Health Co. has a one year low of $43.56 and a one year high of $72.51.

CVS Health (NYSE:CVS) last announced its earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 EPS for the quarter, topping analysts’ consensus estimates of $1.62 by $0.63. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. The firm had revenue of $94.59 billion during the quarter, compared to analysts’ expectations of $93.07 billion. During the same quarter in the previous year, the business earned $1.31 EPS. The company’s quarterly revenue was up 7.0% on a year-over-year basis. Equities analysts expect that CVS Health Co. will post 5.89 EPS for the current year.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, May 1st. Investors of record on Tuesday, April 22nd were issued a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 3.95%. The ex-dividend date was Tuesday, April 22nd. CVS Health’s payout ratio is currently 63.48%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.